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Infertility is a condition that occurs very frequently and understanding what defines normal fertility is crucial to helping patients.
Causes of infertility are numerous and the treatment often does not lead to desired pregnancy especially when there is a lack of
functional gametes. In humans, the primordial germ cell (PGC) is the primary undifferentiated stem cell type that will differentiate
towards gametes: spermatozoa or oocytes. With the development of stem cell biology and differentiation protocols, PGC can be
obtained from pluripotent stem cells providing a new therapeutic possibility to treat infertile couples. Recent studies demonstrated
that viable mouse pups could be obtained from in vitro differentiated stem cells suggesting that translation of these results to human
is closer. Therefore, the aim of this review is to summarize current knowledge about PGC indicating the perspective of their use in
both research and medical application for the treatment of infertility.
1. Introduction
Today, in the second decade of this millennium, infertility
remains a global condition with a high prevalence of occur-
rence [1, 2]. Boivin et al. [3] revealed that the rate of 12-month
prevalence ranges from 3.5% to 16.7% in more developed and
from 6.9% to 9.3% in less-developed countries, with an aver-
age prevalence of 9%.The diagnosis of infertilitymay become
a cause of life crisis in many couples, so it is necessary to
develop mechanisms to overcome temporary or permanent
loss of fertility and the possibility to have a biological child [1].
For infertile couples that are unable to have a child by other
treatments, artificial reproductive technique (ART) and the
possibility to derive gametes from stem cells offer potential
reproductive strategies to individuals who are infertile due
to injuries, exposure to toxicants, or immune-suppressive
treatments and suffer from gonadal insufficiency due to pre-
mature ovarian failure or azoospermia, reproductive aging,
and idiopathic cases of poor gamete quality [4, 5].
In most multicellular organisms, germ cells are the origin
of new organisms that provide the inheritance of the genetic
and epigenetic information in the following generations [6].
The germ cell lineage is the source of totipotency, providing
the creation of new organisms [7]. In the 19th century, August
Weismann published the hypothesis according to which the
presence of preformed germ cell determinants (germplasm)
are inherited only through the germ cells ensuring the
totipotency and continuity of the germ line [8].This has been
demonstrated in invertebrates and lower vertebrates, where
the germplasm is required for germ cell formation, while
in mammals, this process involves epigenetic mechanisms
and not preformation. That regulated event, in which some
environmental influences play a crucial role, and totipotency
is maintained through the germ line, allowing further devel-
opment in the following generation.
Germ cells undergo two significantly different develop-
mental phases [9].The first phase occurs during early embry-
ogenesis, when primordial germ cells (PGCs) are formed and
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actively migrate to the gonadal ridge [10, 11]. In the second
phase, the germ cells receive appropriate signals from their
environment and initiate one of two distinct programs of con-
trolled cell division, meiosis, and differentiation-oogenesis or
spermatogenesis, to form gametes. The molecular basis of
both processes and early germ cell development is very well
understood in two species, Drosophila and Caenorhabditis
elegans, where systematic genetic reviews have identified
many of the genes required in this process [12–15]. PGCs in
humans have not been intensely investigated because of the
technical and ethical obstacles to obtaining such cells from
early embryos [16]. The greater part of our knowledge of
mammalian PGC specification has been obtained from stud-
ies using early mouse embryos, in which the germ cell fate
is induced in pluripotent proximal epiblast cells soon after
implantation in the uterine wall [17].
In this review we summarize current knowledge about
mammalian PGC and indicate the perspective of their use in
research and to generate mature gametes that could be used
in treatment of human infertility.
2. Origin and Development of
Primordial Germ Cells
In mammals, the origin of the germ cell lineage in embryoge-
nesis was initially unclear due to the absence of the character-
istic germplasm present in the egg as seen in other organisms
such as X. laevis and D. melanogaster [17]. PGCs were first
identified in mammals by Chiquoine in 1954 [18]. He found
a population of germ cell lineage cells capable of generating
both, oocytes and spermatozoa at the base of the emerging
allantois at E7.25 in the endoderm of the yolk sac of mouse
embryos, immediately below the primitive streak, identified
by high alkaline phosphatase (AP) activity. While ethical
constraints limit our knowledge of the specification of human
PGC, it is clear that common signaling pathways operate
acrossmammals and possibly all vertebrates [19]. Based upon
staining of AP different studies have suggested diverse sites
of origin for the PGC including the posterior primitive streak
(reviewed in [20]). The founder population of germ cells is
few in number and deeply which causes major difficulties in
studying the genetic basis for the specification of the germ
cell lineage [8]. Germcells, soon after their lineage restriction,
acquire morphology which would reflect underlying unique
molecular features. Saitou et al. have established a system to
identify key factors that determine germ cell fate in mouse
and to understand the distinctive features that the germ cells
acquire at the molecular levels [21]. They dissected out an
embryonic region with around 300 cells that contained the
founder germ cells at E7.5 (EB stage) and dissociated it into
single cells. These cells are morphologically similar but fall
into two classes distinguishable by differential expression of
two germcell-specific genes, Stella andFragilis [8].The cluster
of 300 cells demonstrates universal expression of Fragilis but
Stella expression is restricted to a subset of cells within the
centre of the cluster. Therefore, both genes appear to have
major roles in germ cell development and their ability to
differentiate [21]. Stella is the first gene to be expressed in the
population of cells considered to be lineage restricted germ
cells [8] that also show high expression of tissue nonspecific
AP (Tnap), a gene for AP activity of PGC [22].
Migrating germ cells continue to show strong and specific
expression of Stella but exhibit strong repression of all
the homeobox genes examined (Hoxb1, Hoxa1, Evx1, and
Lim1), despite high levels of expression of these genes in the
neighbouring somatic cells [8]. Since the role of homeobox
genes is to specify the regional identity of cells along the body
axis or induce differentiation of cells towards specific somatic
cell lineages, this suggests that the founder germ cells acquire
the ability to avoid somatic specification by preventing or sup-
pressing homeobox gene expression.This could be one of the
key features that mammalian germ cells possess that allows
them to maintain or regain totipotency and differ from other
surrounding cells in the niche. This concept is supported by
continued expression of Oct4 and other pluripotency genes
in germ cells [23].
In mouse, the specification of germline begins around
E6.25 in the proximal epiblast in a small population of cells
identified by expression of Blimp1 (B-lymphocyte-induced
maturation protein 1)/Prdm1 (Pr domain containing protein
1) [24] and Prdm14 [25]. Interestingly, Blimp1 and Prdm14
have distinct binding patterns relative to promoters [26]
and Blimp1 has a dominant role for PGC specification.
Blimp1 is important for the repression of almost all the genes
normally downregulated in PGCwith respect to their somatic
neighbours, as well as for the restoration of pluripotency and
epigenetic reprogramming. Conversely, Prdm14 regulates the
restoration of pluripotency and epigenetic reprogramming
independently from Blimp1 and defines a novel genetic
pathway with strict specificity to the germ cell lineage [27].
Expression of these two factors starts independently in a
small number of cells of the proximal posterior epiblast at the
beginning of the early-streak stage [28]. These cells increase
in number and form PGC with AP activity and Stella (also
known as Dppa3 or Pgc7) expression [21, 29]. PGCs in
the mouse are induced during gastrulation by bone mor-
phogenetic protein (BMP) signaling and as yet unidentified
signal(s) from the extraembryonic ectoderm and visceral
endoderm to underlying pluripotent epiblast cells at E6.5
[30]. This induction results in Blimp1/Prdm1 mediated tran-
scriptional regulation of epiblast cells which promotes the
expression of PGC-specific genes, such as Stella, and represses
the expression of somatic cell genes such as members of the
Hox gene family [24, 31]. It is still unknown whether the
Smads activate Blimp1 and Prdm14 transcription directly or
indirectly [7]. Determination of the element(s) responsible
forBlimp1 expression in the epiblast in response to BMP4 and
examination of whether or not the Smads directly bind to and
control Blimp1 will be crucial to provide a definitive answer
to this question. Induction of PGC seems to require BMP4 or
BMP8b alone or in combination indicating that signalling for
various BMPs occurs through separate receptors. In mice,
a number of other factors which have been implicated in
specification andmaintenance of PGC occur at around E6.25,
marked by the sequential expression of two transcription
factors Blimp1/Prdm1 and Prdm14 in response to BMPs [32].
Blimp1, Prdm14, and Stella-positive PGC integrate key events
to repress a somatic mesodermal differentiation program in
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Figure 1: Time schedule and signals involved in the regulation of primordial germ cells (PGCs) migration and colonization in mice.
PGC [7]. WNT signalling is also essential for the PGC fate,
possible through posttranscriptional interaction with sug-
gesting that theWNT signalingmay act posttranscriptionally
on BMP signalling components [7]. WNT signaling can sta-
bilize Smad1 by inhibiting GSK3-mediated phosphorylation
of its linker region thereby preventing its degradation [33]
but the tyrosine-kinase receptor c-kit and its ligand, stem cell
factor, are essential for the maintenance of PGC in both sexes
[19].
3. Migration of Primordial Germ Cells
In contrast to D. melanogaster and zebrafish, little is known
about PGC migration and initiation of that process in mice
[33]. Soon after specification, the cells begin to exhibit polar-
ized morphology and cytoplasmic extensions and initiate
migration through the primitive streak into the adjacent pos-
terior embryonic endoderm, extraembryonic endoderm, and
allantois [20]. The first step in mouse PGC migration is the
movement of cells from the posterior primitive streak to the
endoderm at E7.5. Between E8.5 and E13.5, the Tnap positive
PGCs proliferate and migrate via the hindgut endoderm
and mesentery followed by bilateral migration to the genital
ridges, after which they can enter into meiosis in the female
or mitotic arrest in the male and initiate differentiation into
either oocytes or spermatozoa [16, 34]. Duringmigration, the
PGC population doubling time is fairly uniform at about 16
hours between 8.5 and 13.5 days. E13.5mouse embryos should
have about 24000 PGCs in their genital ridges [35]. In this
migratory phase, PGCs undergo extensive genome repro-
gramming and alteration of epigenetic information, such as
DNAmethylation and histonemodification patterns, and the
erasure of gene imprinting that may be essential for restoring
totipotency to the germ cell lineage [16].
Currently, there is no evidence for sex-specific differences
during PGC migration in any organism. A subset of germ
cells in the gonad acquires the ability to function as germline
stem cells, which undergomeiosis to produce sperm and eggs
and promote the next generation of embryonic development
and PGC migration. Vasa protein is an essential component
of germplasm and represents a poorly understood complex of
RNA and proteins that is required for germ cell determina-
tion. Null mutation leads to sterility in female mice resulting
from severe defects in oogenesis [10]. In humans, VASA
expression begins at the end of the migratory phase of PGC
development [9]. Tilgner et al. generated and characterized
human embryonic stem cell (hESC) lines with a construct in
which expression of the pEGFP-1 gene was driven by a DNA
sequence representing the VASA reporter [36]. They demon-
strated that hESC could be used as a development model
system for PGC specification under in vitro conditions. Also,
they were able to establish a small number of the presumed
female PGCs isolated on the basis of VASA promoter driven
GFP fluorescence. These results and the fact that specific
expression of Vasa in the germ cell lineage during colo-
nization of the gonadal ridge suggest that Vasa is required
to maintain the functionality of germ cells. For instance,
male mice homozygous for a targeted mutation of the mouse
Vasa ortholog Mvh are sterile and exhibit severe defects in
spermatogenesis while homozygous females are fertile [37,
38]. Other signals (Figure 1) involved in the regulation of
PGC migration and colonization are the adhesion molecule
E-cadherin [39] and extracellular matrixmolecule integrin 𝛽1
[40, 41]. Unfortunately, the precise function of these factors
and signalling pathways remain to be explained.
Migratory PGCs maintain a genomic program associated
with pluripotency. They express core pluripotency genes
(Oct4, Nanog, and Sox2) and are able to form teratomas after
injection into postnatalmouse testes [6, 42, 43]. Besides these,
migratory PGCs express stage-specific embryonic antigen 1
(SSEA1) [16]. Upon arrival in the gonad, germ cell-specific
RNA binding protein DAZL (deleted in azoospermia-like)
is essential for developing PGC [44]. Many studies revealed
that the DAZL functions as a translational enhancer [45–47].
Knockout for target mRNA binding partners of DAZL (Mvh,
Scp3, and Tex19.1) resulted in severe phenotypic changes [48–
50] suggesting that DAZL may have additional roles during
the PGC stage of mammalian gametogenesis. DAZL is also a
gatekeeper of apoptosis in PGC and regulates the expression
of key Caspases acting as an elegant fail-safe mechanism that
prevents stray PGC from forming teratomas and eliminating
aberrant PGC [51]. In the absence of DAZL, the germ cells fail
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Table 1: Summarized genes that participate into PGC development.
Full name Alternate names Time of expression Location of coded protein References
Tissue nonspecific AP
(Tnap) E7.25-14
At the cell surface, linked to
the cell membrane via a
phosphatidylinositol glycan
linkage
[22]
Stella
Developmental
pluripotency-associated
3 or Dppa3 or Pgc7
E7.5
Protein that may shuttle
between the nucleus and
cytoplasm
[8, 21]
Fragilis E7.5 Transmembrane protein [8, 21]
B-lymphocyte-induced
maturation protein 1
(Blimp1)
Pr domain containing
protein 1 (Prdm1) E6.25
Cytoplasmic transcriptional
repressor [24]
Prdm14 Pr domain containingprotein 14 E6.25 Transcriptional regulator [25]
Mouse Vasa ortholog
(Mvh)
E13.5(10.5) end of the
migratory phase of
PGC development
Cytoplasm [9]
Deleted in
azoospermia-like
(DAZL)
E12.5(11.5) Cytoplasmic protein [44–52]
to develop beyond the PGC stage as shown by continued
expression of pluripotency markers. These findings suggest
that DAZL is a “licensing factor” required for sexual dif-
ferentiation of PGC [52]. Genes that participate in PGC
development are summarized in Table 1.
Postmigration PGCs, marked by the expression of several
RNA binding proteins such as MVH, DAZL, and NANOS3,
undergo sexual dimorphic development [46–53]. In mice,
female germ cells quickly initiatemeiosis and arrest atmeiosis
I stage, while male ones mitotically divide for several rounds
and then enter a quiescent stage when they are known as
gonocytes. Specifically, the PGCs upregulate a set of genes
that enable them to undergo sexual differentiation and game-
togenesis while suppressing their pluripotency program [54].
In the female XX embryo, the PGCs continue to prolifer-
ate and subsequently enter into the prophase I of meiotic
divisions [35]. Hereafter, they are arrested at the diplotene
stage of prophase I of meiosis. After birth, the gonocytes are
surrounded by cells from the cortical interstitial layer and
become primary oocytes in primordial follicles, thereby end-
ing precursor proliferative potential and arresting their devel-
opment process until puberty. After puberty, hormonal stim-
ulation during ovulation causes the maturation and release
of oocytes from the ovary into the oviduct followed by com-
pletion of the first meiotic division with concomitant extru-
sion of the first polar body. Upon fertilization with a haploid
spermatozoon, the oocyte completes the second meiotic
division and extrudes the second polar body [6, 55, 56].
In contrast to those in the female, XY PGCs enter into
mitotic arrest upon entry into the genital ridges and stay
quiescent in the G
0
/G
1
phase of the cell cycle for the
remaining embryonic period as a prospermatogonium, while
retaining a proliferative precursor potential [57]. Around day
5 postpartum, many of prospermatogonia resume active pro-
liferation, while some migrate to the basement membrane of
the seminiferous tubule and form tight junctions with Sertoli
cells thereby forming spermatogonial stem cells (SSC) incor-
porated into their appropriate niche.Thus, comparedwith the
very limited size of the oocyte pools, the spermatozoa can
be obtained from differentiation of SSC. In culture, germline
stem cells bearing the abilities for long-term proliferation
and for spermatogenesis upon transplantation into testes
are established in the presence of GDNF (glial cell-derived
neurotrophic factor), most readily fromneonatal testes [6, 55,
56].
4. Derivation of PGC from Pluripotent Cells
PGC can be isolated from whole mouse embryos at E6.0 in
serum- and feeder-free conditions in suspension [7]. Under
such conditions leukaemia inhibitory factor has an activity
to suppress the induction of goosecoid, a marker for the
mesendoderm, which suggests that Blimp1 expression in the
serum-free mediummight reflect a differentiation of epiblast
cells into a mesendodermal lineage. The data indicate that
essentially all epiblast cells at E6.0, if separated from visceral
endoderm a source for inhibitory signals, are able to express
Blimp1 in response to BMP4 alone (Figure 1). Until now,
evidence has been provided that isolated epiblasts can be
induced to form Blimp1, Prdm14, and AP-positive PGC-like
cells after 36 hours in a serum-free culture with BMP4 [58].
Meanwhile differentiation of hESC to PGC has substan-
tial potential as a method to examine the mechanisms of
normal and abnormal development of human germline. To
derive larger numbers of human PGCs from hESC Tilgner
et al. [16] have developed an in vitro growth system that
demonstrates the usefulness of SSEA1 to enrich a population
of putative PGC.The SSEA1-positive cells sharemany charac-
teristics with ex vivo PGC, such as the expression of key genes
(VASA,OCT4, and STELLA), but their cell-cycle status differs
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Figure 2: Making gametes from pluripotent stem cells (PSC). Primordial germ cells (PGCs), embryonic germ cells (EGCs).
from previous observations in embryonic mice, indicating
that PGCs from E9.0 were largely arrested in G2/M, while
the SSEA1-positive population is largely in S-phase, which
suggests that the majority of the cells may still be in their
mitotic expansion phase. Therefore, targeted differentiation
of human pluripotent stem cells (PSC) offers an excellent
opportunity to investigate the mechanisms involved in matu-
ration of PGC. However, the limited number of publications
indicates that the derivation of germ cells from PSC is still
an immature technology [59–61]. The first reported study of
induction ofmouse germcells fromPSCwas study byHu¨bner
et al. [60] but Hayashi et al. [62] were the first to describe the
high efficiency two-step procedure to obtain PGC-like cells
(PGCLC) frommouse ESC and iPSC. In this procedure, ESC
and iPSC were first induced into epiblast-like cells that were
subsequently induced to PGCLC [62] and later ESC could
be differentiated towards germ cells [63]. Chuma et al. [42]
transplanted PGC in testis and obtained mature sperm
whereas Matoba and Ogura [64] reported that PGCs isolated
from E12.5 male foetus under the kidney capsule yield sper-
matids (Figure 2). The milestone of these studies is the birth
of healthy offspring. Similar toMatoba andOguraHashimoto
et al. [65] reported that PGCs isolated from female foetus
when transplanted under the ovarian bursa or kidney capsule
result in functional oocytes. Therefore, we are a step closer
to obtaining human gametes from in vitro produced PGC
using ESC or iPSC [62, 66, 67] but in human some obstacles
remain: (i) how tomake the PGC to convert tomature oocyte
without transplantation and (ii) how to repeat the mouse
work in humans to produce PGC for infertility treatment.
Nevertheless, the advantage of using hESC and patient-
specific iPSC is the possibility to decipher the mechanisms
involved in differentiation andmaturation of human gametes
with the aim of completely translating gene expression profil-
ing of these cells. This can be confirmed by previous publica-
tion [68] with clear evidence that the SOX17 is the key regu-
lator of human PGC fate. The study revealed that the Blimp1
is downstream of SOX17 and represses endodermal and other
somatic genes during specification of humanPGC,whichwas
unexpected since Sox17 does not have role in specification
of mouse PGC. Once we have in our hands the protocol
to drive differentiation of human iPSC towards functional
gametes we will be able to produce patient-specific oocytes
and spermatozoa under controlled in vitro conditions.
5. Conclusion
The possibility of generating mature gametes from PGC
represents an area of investigation that provides more
insight into signalling pathways of gametogenesis and repro-
ductive dysfunction in humans. Very recent progress in
work with targeted differentiation of iPSC offers tailor-
made/personalized iPSC therapies also for the treatments of
azoospermia in males or primary ovarian insufficiency in
females [69–73]. However, problems in derivation of sperm
cells and oocytes under in vitro conditions in human remain:
the differentiation of germ cells is dependent on the somatic
environment rather than the sex chromosome content of the
germ cell. Therefore, the demonstration of gametogenesis
from cultures of differentiatingmouse ESC and iPSC suggests
that “artificial” human gametes may also be obtained in this
way, and the live birth of mouse pups suggests that the
human cells may also be functional, although the successful
demonstration of human gamete formation in this way is still
awaited, but already followed by numerous ethical discus-
sions. Nevertheless, obtaining of human viable spermatozoa
and oocytes under in vitro conditions would for sure open in
reproductive medicine new horizons to a new form of infer-
tility treatment.
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